A therapeutic trial of Atromid® in multiple sclerosis
- 1 December 1967
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 17 (12) , 1185
- https://doi.org/10.1212/wnl.17.12.1185
Abstract
A double-blind therapeutic trial of Atromid in multiple sclerosis involving 40 patients studied for 20 months showed this preparation to have no significant effect on the clinical course of the disease.This publication has 5 references indexed in Scilit:
- PLATELET STICKINESS IN MULTIPLE SCLEROSISThe Lancet, 1965
- EFFECT OF ETHYL CHLOROPHENOXYISOBUTYRATE WITH OR WITHOUT ANDROSTERONE ON PLATELET STICKINESSThe Lancet, 1964
- Some Effects of Atromid on Platelet Economy and Blood Coagulation in ManJournal of Atherosclerosis Research, 1963
- Effect of atromid on platelet stickinessJournal of Atherosclerosis Research, 1963
- On the evaluation of disability in multiple sclerosisNeurology, 1961